Turkey / Koçak Farma & The Push for Homegrown COVID-19 Vaccines
As the international community continues its quest to vaccinate the global population against COVID-19, shortages…
Vaccines
Moderna / Bullish Bancel “Not Losing Sleep” over COVID-19 Vaccine IP Waiver, Looking to mRNA’s Future in Rare Diseases & Oncology
The day the Biden administration announced its support for the waiver of IP rights for COVID-19 vaccines, Moderna’s stock fell six percent; the day after that, another two percent. However,…
Europe / Vaccine Wars: What the EU/AstraZeneca Row Shows Us About Pharma Cross-Border Litigation
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and litigation examines the origins and…
Switzerland / Lonza Goes Big with Investments in Biologics, ADCs & Vaccines Manufacturing
In the last month alone, CDMO giant Lonza has announced three major upgrades to its manufacturing footprint in…
In Conversation
Pierre Meulien – Executive Director, Innovative Medicines Initiative (IMI)
Dr Pierre Meulien, executive director of the Innovative Medicines Initiative (IMI), the world’s largest life science public-private partnership between the European Union and the European pharmaceutical industry, shares the incredible work IMI has been doing through the COVID-19 pandemic, along with the critical importance of public-private partnerships for areas like vaccines and antimicrobial resistance (AMR), and gives an exciting preview…
Vaccines / Top 10 Companies
Vaccines are back on top of the pharma priority list as companies race against the clock to develop the first…
Switzerland / Lonza Goes Big with Investments in Biologics, ADCs & Vaccines Manufacturing
In the last month alone, CDMO giant Lonza has announced three major upgrades to its manufacturing footprint in…
Canada / COVID-19 Vaccination Strategies
Fasken Canada’s Dara Jospe and Denis Douville examine Canada’s COVID-19 vaccine strategy, from the…
GSK / 6 Key Takeaways from Vaccines Head Roger Connor at FT Conference
During the FT Global Pharmaceutical and Biotechnology Conference last week, GSK global vaccines president Roger…
Vaccines / IFPMA's Thomas Cueni on why "#TeamVaccines is all of us"
Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) highlights…
A Critical Juncture for the UK’s Vaccines Industry
Britain, home of the discovery of the world’s first ever vaccine, has long been championing a pharma sub-segment…
China / Antitrust Threat to Pharma; June BioNTech Vaccine Approval; EpimAb IPO; CanSino Inhaled Vaccine Trials
The latest China pharma news, including the upcoming first domestic approval for a foreign COVID-19 vaccine in…
COVID-19 Vaccines / AstraZeneca, GSK, J&J & Pfizer Execs’ Key Concerns
During the 28 May 2020 IFPMA media briefing on COVID-19 vaccines, four of the pharmaceutical industry’s leading…
Global / Innovative Pharma Doubles Down on IP with New Pact
On World Intellectual Property (IP) Day 2021, the innovative biopharmaceutical industry came together to launch a…
Europe / Vaccine Wars: What the EU/AstraZeneca Row Shows Us About Pharma Cross-Border Litigation
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and litigation examines the origins and…
Italy / Menarini CEO on Averting Future Health Crises; Alfasigma Hackathon; January COVID Vaccines
A roundup of some of the most important recent stories from Italian pharma, including an in-depth interview with…
Vaccines / An Expanded R&D Playbook
The story of how British doctor Edward Jenner serendipitously discovered a way to inoculate people against smallpox…
COVID-19 Vaccines / Valneva: A Success Story for France?
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…
Russian bots targeted US and vaccines
In the latest twist in the ongoing story of Russian interference in the US presidential elections of 2016, it has…
Opinion / Speeding up the Search for Safe & Effective COVID-19 Therapies & Vaccines
IFPMA Director General Thomas B. Cueni shares the outcomes of a recent high level pharma industry media briefing on…
GSK / Senior VP for Vaccines R&D on COVID-19 Collaboration
GSK, the world’s largest manufacturer of vaccines, has pursued a different strategy to that of its contemporaries…
Vaccines / Sustaining the Ecosystem Benefits Public Health
Francois Sandre, Head of Asia & JPAC for Sanofi Pasteur outlines the importance of a sustainable global vaccine…
Mexico-US Vaccine Tourism / Closed Borders, Fear of Fakes & Plane Crashes
While Mexico struggles with its COVID-19 vaccination campaign, residents of the country’s northern states have…
Turkey / Koçak Farma & The Push for Homegrown COVID-19 Vaccines
As the international community continues its quest to vaccinate the global population against COVID-19, shortages…
USA / U-Turn as Biden Pledges Support for Waiver on COVID-19 Vaccine IP
In a shock move, Joe Biden’s administration looks set to support a waiver on intellectual property (IP)…